Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xavier Anglaret

Showing results (21-30 of 161) with videos related to

Pageof 17
Sort By:
AIDS (London, England)|September 9, 2004
High incidence of atypical mycobacteriosis in African HIV-infected adults with low CD4 cell counts: a 6-year cohort study in Côte d'IvoireDominique Bonard, Eugène Messou, Catherine Seyler, et al.
Journal of the International AIDS Society|September 5, 2012
HIV treatment and care in resource-constrained environments: challenges for the next decadeSerge-Paul Eholié, François Eba Aoussi, Ismael Songda Ouattara, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 6, 2006
Nonantiretroviral drug consumption by CD4 cell count in HIV-infected adults: a 5-year cohort study in Côte d'IvoireNohelly Nombela, Bertin Kouadio, Siaka Toure, et al.
AIDS (London, England)|March 8, 2005
Decreasing incidence of pregnancy by decreasing CD4 cell count in HIV-infected women in Côte d'Ivoire: a 7-year cohort studyMarc-Arthur Loko, Siaka Toure, Nicole Dakoury-Dogbo, et al.
American Journal of Epidemiology|March 5, 2005
Use of a Bayesian approach to decide when to stop a therapeutic trial: the case of a chemoprophylaxis trial in human immunodeficiency virus infectionAlphonse Kpozèhouen, Ahmadou Alioum, Xavier Anglaret, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 19, 2018
Reply to Hector et alGérard-Menan Kouamé, Anders Boyd, Raoul Moh, et al.
The Lancet. Infectious Diseases|December 2, 2014
Dose regimen of favipiravir for Ebola virus diseaseFrance Mentré, Anne-Marie Taburet, Jeremie Guedj, et al.
AIDS Research and Therapy|July 28, 2016
Antiretroviral treatment regardless of CD4 count: the universal answer to a contextual questionSerge P Eholié, Anani Badje, Gérard M Kouame, et al.
HIV Clinical Trials|February 11, 2009
Depressive symptoms and exposure to efavirenz in West African HIV-infected adultsFabienne Marcellin, Raoul Moh, Maria Patrizia Carrieri, et al.
Bulletin of the World Health Organization|October 20, 2015
New indicators for delay in initiation of antiretroviral treatment: estimates for CameroonJacques D A Ndawinz, Xavier Anglaret, Eric Delaporte, et al.
Pageof 17

Showing results (21-30 of 161) with videos related to

Sort By:
Pageof 17
AIDS (London, England)|September 9, 2004
High incidence of atypical mycobacteriosis in African HIV-infected adults with low CD4 cell counts: a 6-year cohort study in Côte d'IvoireDominique Bonard, Eugène Messou, Catherine Seyler, et al.
Journal of the International AIDS Society|September 5, 2012
HIV treatment and care in resource-constrained environments: challenges for the next decadeSerge-Paul Eholié, François Eba Aoussi, Ismael Songda Ouattara, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 6, 2006
Nonantiretroviral drug consumption by CD4 cell count in HIV-infected adults: a 5-year cohort study in Côte d'IvoireNohelly Nombela, Bertin Kouadio, Siaka Toure, et al.
AIDS (London, England)|March 8, 2005
Decreasing incidence of pregnancy by decreasing CD4 cell count in HIV-infected women in Côte d'Ivoire: a 7-year cohort studyMarc-Arthur Loko, Siaka Toure, Nicole Dakoury-Dogbo, et al.
American Journal of Epidemiology|March 5, 2005
Use of a Bayesian approach to decide when to stop a therapeutic trial: the case of a chemoprophylaxis trial in human immunodeficiency virus infectionAlphonse Kpozèhouen, Ahmadou Alioum, Xavier Anglaret, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 19, 2018
Reply to Hector et alGérard-Menan Kouamé, Anders Boyd, Raoul Moh, et al.
The Lancet. Infectious Diseases|December 2, 2014
Dose regimen of favipiravir for Ebola virus diseaseFrance Mentré, Anne-Marie Taburet, Jeremie Guedj, et al.
AIDS Research and Therapy|July 28, 2016
Antiretroviral treatment regardless of CD4 count: the universal answer to a contextual questionSerge P Eholié, Anani Badje, Gérard M Kouame, et al.
HIV Clinical Trials|February 11, 2009
Depressive symptoms and exposure to efavirenz in West African HIV-infected adultsFabienne Marcellin, Raoul Moh, Maria Patrizia Carrieri, et al.
Bulletin of the World Health Organization|October 20, 2015
New indicators for delay in initiation of antiretroviral treatment: estimates for CameroonJacques D A Ndawinz, Xavier Anglaret, Eric Delaporte, et al.
Pageof 17